Index RUT
P/E 37.67
EPS (ttm) 0.78
Insider Own 2.87%
Shs Outstand 46.48M
Perf Week -0.24%
Market Cap 1.36B
Forward P/E 8.21
EPS next Y 3.56
Insider Trans -8.21%
Shs Float 45.16M
Perf Month -2.31%
Income 41.95M
PEG 3.62
EPS next Q 0.65
Inst Own 106.02%
Short Float 9.02%
Perf Quarter -14.84%
Sales 674.98M
P/S 2.01
EPS this Y 0.08%
Inst Trans 2.38%
Short Ratio 8.02
Perf Half Y -5.86%
Book/sh 18.72
P/B 1.56
EPS next Y 26.54%
ROA 2.58%
Short Interest 4.07M
Perf Year -26.79%
Cash/sh 5.99
P/C 4.88
EPS next 5Y 10.40%
ROE 5.10%
52W Range 25.93 - 48.60
Perf YTD -13.40%
Dividend Est. -
P/FCF 9.74
EPS past 5Y -
ROI 2.92%
52W High -39.88%
Beta 0.76
Dividend TTM -
Quick Ratio 4.17
Sales past 5Y 15.46%
Gross Margin 64.15%
52W Low 12.69%
ATR (14) 1.02
Dividend Ex-Date -
Current Ratio 5.24
EPS Y/Y TTM 155.39%
Oper. Margin 12.94%
RSI (14) 46.48
Volatility 3.31% 3.70%
Employees 712
Debt/Eq 0.67
Sales Y/Y TTM 1.22%
Profit Margin 6.22%
Recom 1.20
Target Price 45.30
Option/Short Yes / Yes
LT Debt/Eq 0.65
EPS Q/Q 316.94%
Payout 0.00%
Rel Volume 1.12
Prev Close 29.04
Sales Surprise 0.35%
EPS Surprise 0.76%
Sales Q/Q 5.40%
Earnings Feb 29 BMO
Avg Volume 507.79K
Price 29.22
SMA20 -1.52%
SMA50 -3.46%
SMA200 -10.25%
Trades
Volume 569,631
Change 0.62%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-07-24 Resumed
JP Morgan
Overweight
$80 → $45
Dec-20-23 Initiated
Raymond James
Outperform
$42
Aug-03-23 Upgrade
TD Cowen
Market Perform → Outperform
$50
Jan-31-23 Resumed
Wedbush
Outperform
$88 → $60
Oct-21-22 Resumed
Jefferies
Buy
$66
Jan-03-22 Resumed
JP Morgan
Overweight
$75 → $83
Jul-26-21 Upgrade
JP Morgan
Neutral → Overweight
$75
Apr-21-21 Resumed
JP Morgan
Neutral
$70
Apr-09-21 Initiated
Berenberg
Buy
$93
Apr-07-21 Resumed
RBC Capital Mkts
Outperform
$86
Feb-11-21 Downgrade
Northland Capital
Outperform → Market Perform
$72 → $75
Jan-21-21 Downgrade
SVB Leerink
Outperform → Mkt Perform
$75
Sep-21-20 Upgrade
Northland Capital
Market Perform → Outperform
$58 → $67
Jul-06-20 Reiterated
Needham
Buy
$52 → $64
May-27-20 Initiated
Guggenheim
Neutral
Apr-07-20 Initiated
Northland Capital
Outperform
$50
Mar-20-20 Upgrade
SVB Leerink
Mkt Perform → Outperform
$44
Feb-24-20 Reiterated
H.C. Wainwright
Buy
$60 → $63
Jan-24-20 Initiated
SunTrust
Buy
Jan-23-20 Initiated
SunTrust
Buy
Show Previous Ratings
Mar-14-24 08:23AM
Mar-13-24 07:00AM
Mar-08-24 11:55PM
Mar-06-24 08:00AM
Mar-04-24 08:28PM
08:38AM
Loading…
Mar-01-24 08:38AM
06:05AM
12:28AM
(Thomson Reuters StreetEvents)
Feb-29-24 10:00AM
09:15AM
08:32AM
08:26AM
(Associated Press Finance)
08:00AM
Feb-22-24 08:00AM
Feb-15-24 08:36AM
08:00AM
Loading…
Feb-07-24 08:00AM
Feb-01-24 10:45AM
Jan-05-24 12:21PM
Jan-04-24 05:00PM
Jan-03-24 08:00AM
Dec-21-23 07:30AM
Dec-06-23 11:13AM
Nov-13-23 10:10AM
Nov-10-23 07:30AM
Nov-07-23 08:00AM
Nov-04-23 10:28AM
Nov-02-23 12:34PM
10:00AM
08:23AM
(Associated Press Finance)
08:00AM
08:00AM
Loading…
Oct-26-23 08:00AM
Oct-12-23 08:00AM
Oct-10-23 08:00AM
Oct-02-23 08:00AM
Sep-27-23 12:07PM
11:50AM
Sep-26-23 04:30PM
Sep-06-23 08:00AM
Aug-03-23 10:03AM
Aug-02-23 12:45PM
08:11AM
08:00AM
Jul-28-23 02:56PM
Jul-26-23 08:00AM
Jun-21-23 08:00PM
Jun-02-23 11:31AM
May-31-23 08:00AM
May-09-23 08:00AM
May-03-23 11:42PM
(Thomson Reuters StreetEvents) -7.17%
05:25PM
03:11PM
08:11AM
08:00AM
Apr-26-23 08:00PM
08:00AM
Apr-20-23 09:20AM
08:00AM
Apr-19-23 08:00AM
Apr-12-23 08:00AM
Apr-03-23 08:00AM
Mar-30-23 11:30AM
Mar-29-23 08:00AM
Mar-27-23 08:00AM
Mar-24-23 08:50AM
Mar-22-23 08:00AM
Mar-09-23 09:17AM
Mar-08-23 08:00AM
Feb-28-23 11:39PM
(Thomson Reuters StreetEvents)
08:00AM
Feb-23-23 08:00AM
Feb-21-23 08:00AM
Jan-05-23 04:30PM
Jan-04-23 08:00AM
Dec-20-22 10:06AM
Dec-13-22 08:00AM
Nov-18-22 01:38PM
Nov-17-22 08:05AM
Nov-14-22 08:00AM
Nov-09-22 05:14AM
Nov-08-22 08:00AM
Nov-04-22 10:54AM
Nov-03-22 09:15AM
08:00AM
Nov-01-22 10:01AM
Oct-27-22 10:02AM
Oct-20-22 08:00AM
Oct-15-22 08:34AM
Oct-13-22 08:00AM
Oct-07-22 02:10PM
(Investor's Business Daily)
Sep-27-22 08:00AM
Sep-21-22 06:04PM
10:08AM
08:00AM
Sep-20-22 08:00AM
Sep-13-22 08:00AM
Sep-08-22 10:42AM
Sep-07-22 11:07AM
07:00AM
Sep-02-22 11:31AM
Aug-10-22 08:00AM
Pacira Biosciences, Inc. is a holding company, which engages in the provision of non-opioid pain management and regenerative health solutions to improve patients' journeys along the neural pain pathway. Its products include EXPAREL, iovera, and DepoFoam. The company was founded in December 2006 and is headquartered in Tampa, FL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
PACE GARY W Director Mar 08 '24 Sale 30.60 90,000 2,754,000 22,127 Mar 08 05:33 PM PACE GARY W Director Mar 07 '24 Sale 30.81 28,257 870,598 112,127 Mar 08 05:33 PM PACE GARY W Director Mar 06 '24 Sale 29.67 1,066 31,628 140,384 Mar 08 05:33 PM WINSTON ROY Chief Medical Officer Aug 02 '23 Sale 34.88 509 17,751 52,440 Aug 04 04:47 PM Riker Lauren Bullaro Senior Vice President, Finance Jul 05 '23 Sale 38.91 643 25,019 22,687 Jul 07 08:04 PM Riker Lauren Bullaro Senior Vice President, Finance Jun 14 '23 Sale 38.42 6,366 244,606 22,687 Jun 16 05:39 PM Williams Kristen Marie Chief Administrative Officer Jun 14 '23 Sale 37.03 6,467 239,473 25,375 Jun 16 05:42 PM Kronenfeld Mark A. Director Jun 08 '23 Option Exercise 29.90 15,000 448,500 32,897 Jun 12 04:16 PM Kronenfeld Mark A. Director Jun 08 '23 Sale 37.04 15,000 555,600 17,897 Jun 12 04:16 PM STACK DAVID M CEO and Chairman Jun 07 '23 Sale 37.87 5,326 201,669 153,781 Jun 07 09:33 PM WINSTON ROY Chief Medical Officer Jun 07 '23 Sale 37.87 1,857 70,315 41,356 Jun 07 09:36 PM Reinhart Charles A. III Chief Financial Officer Jun 07 '23 Sale 37.87 1,371 51,913 33,626 Jun 07 09:29 PM Williams Kristen Marie Chief Administrative Officer Jun 07 '23 Sale 37.87 1,357 51,383 20,892 Jun 07 09:34 PM Ellis Ronald J. Jr. Chief Strategy Officer Jun 07 '23 Sale 37.87 1,162 43,999 30,909 Jun 07 09:20 PM REINHARDT MAX President, Rest of World Jun 07 '23 Sale 37.87 1,099 41,614 29,225 Jun 07 09:28 PM McLoughlin Dennis Chief Customer Officer Jun 07 '23 Sale 37.87 1,057 40,023 38,115 Jun 07 09:24 PM GAUGLER DARYL Chief Operating Officer Jun 07 '23 Sale 37.87 1,047 39,645 21,539 Jun 07 09:22 PM Riker Lauren Bullaro Senior Vice President, Finance Jun 07 '23 Sale 37.87 616 23,325 19,053 Jun 07 09:31 PM SLONIN JONATHAN Chief Clinical Officer Jun 07 '23 Sale 37.87 490 18,554 36,323 Jun 07 09:32 PM STACK DAVID M CEO and Chairman Jun 06 '23 Sale 38.99 5,058 197,216 159,107 Jun 07 09:33 PM MOLLOY ANTHONY Chief Lgl & Compliance Officer Jun 06 '23 Sale 38.55 4,521 174,285 12,877 Jun 07 09:26 PM WINSTON ROY Chief Medical Officer Jun 06 '23 Sale 38.99 1,779 69,365 43,213 Jun 07 09:36 PM Williams Kristen Marie Chief Administrative Officer Jun 06 '23 Sale 38.99 1,301 50,727 22,249 Jun 07 09:34 PM Reinhart Charles A. III Chief Financial Officer Jun 06 '23 Sale 38.99 1,236 48,193 34,997 Jun 07 09:29 PM Ellis Ronald J. Jr. Chief Strategy Officer Jun 06 '23 Sale 38.99 1,114 43,436 32,071 Jun 07 09:20 PM REINHARDT MAX President, Rest of World Jun 06 '23 Sale 38.99 1,054 41,097 30,324 Jun 07 09:28 PM McLoughlin Dennis Chief Customer Officer Jun 06 '23 Sale 38.99 1,014 39,537 39,172 Jun 07 09:24 PM GAUGLER DARYL Chief Operating Officer Jun 06 '23 Sale 38.99 1,005 39,186 22,586 Jun 07 09:22 PM Riker Lauren Bullaro Senior Vice President, Finance Jun 06 '23 Sale 38.99 591 23,044 19,669 Jun 07 09:31 PM SLONIN JONATHAN Chief Clinical Officer Jun 06 '23 Sale 38.99 471 18,365 36,813 Jun 07 09:32 PM MOLLOY ANTHONY Chief Lgl & Compliance Officer Jun 05 '23 Sale 38.28 2,267 86,774 17,398 Jun 07 09:26 PM GAUGLER DARYL Chief Operating Officer Jun 05 '23 Sale 38.74 1,000 38,740 23,591 Jun 07 09:22 PM Brege Laura Director Jun 05 '23 Sale 38.74 600 23,244 9,547 Jun 07 09:18 PM HASTINGS PAUL J Director Jun 05 '23 Sale 38.34 580 22,237 6,599 Jun 07 09:23 PM GAUGLER DARYL Chief Operating Officer May 31 '23 Option Exercise 34.00 2,500 85,000 26,894 Jun 02 06:28 PM GAUGLER DARYL Chief Operating Officer May 31 '23 Sale 39.08 2,500 97,700 24,591 Jun 02 06:28 PM HASTINGS PAUL J Director May 15 '23 Option Exercise 29.90 7,000 209,300 14,179 May 17 04:07 PM HASTINGS PAUL J Director May 15 '23 Sale 41.85 7,000 292,950 7,179 May 17 04:07 PM PACE GARY W Director May 11 '23 Option Exercise 29.90 7,000 209,300 144,690 May 15 06:53 PM PACE GARY W Director May 11 '23 Sale 41.78 5,015 209,527 139,675 May 15 06:53 PM Brege Laura Director Apr 03 '23 Option Exercise 29.90 7,000 209,300 17,147 Apr 05 04:34 PM Brege Laura Director Apr 03 '23 Sale 40.72 7,000 285,040 10,147 Apr 05 04:34 PM
Index -
P/E -
EPS (ttm) -0.15
Insider Own 0.44%
Shs Outstand 408.82M
Perf Week 3.40%
Market Cap 364.18M
Forward P/E -
EPS next Y -0.13
Insider Trans -1.08%
Shs Float 407.04M
Perf Month -32.52%
Income -59.26M
PEG -
EPS next Q -0.03
Inst Own 23.55%
Short Float 4.47%
Perf Quarter -1.04%
Sales 308.22M
P/S 1.18
EPS this Y 6.67%
Inst Trans -7.25%
Short Ratio 8.15
Perf Half Y -2.78%
Book/sh 1.35
P/B 0.66
EPS next Y 9.52%
ROA -6.90%
Short Interest 18.19M
Perf Year -41.78%
Cash/sh 0.79
P/C 1.13
EPS next 5Y 38.90%
ROE -10.33%
52W Range 0.65 - 1.58
Perf YTD 2.39%
Dividend Est. -
P/FCF -
EPS past 5Y 17.93%
ROI -10.57%
52W High -43.62%
Beta 1.99
Dividend TTM -
Quick Ratio 1.80
Sales past 5Y 14.60%
Gross Margin 53.00%
52W Low 36.84%
ATR (14) 0.06
Dividend Ex-Date -
Current Ratio 2.80
EPS Y/Y TTM 44.82%
Oper. Margin -18.41%
RSI (14) 42.80
Volatility 5.15% 7.45%
Employees 275
Debt/Eq 0.02
Sales Y/Y TTM -16.19%
Profit Margin -19.23%
Recom 3.00
Target Price 1.08
Option/Short Yes / Yes
LT Debt/Eq 0.02
EPS Q/Q -780.95%
Payout -
Rel Volume 0.52
Prev Close 0.89
Sales Surprise 12.76%
EPS Surprise 62.83%
Sales Q/Q -17.11%
Earnings Feb 29 BMO
Avg Volume 2.23M
Price 0.89
SMA20 -1.13%
SMA50 -17.63%
SMA200 -10.24%
Trades
Volume 1,153,032
Change 0.18%
Date
Action
Analyst
Rating Change
Price Target Change
Nov-20-23 Resumed
JP Morgan
Underweight
Oct-25-23 Downgrade
Jefferies
Buy → Hold
$3 → $1
Jan-06-23 Upgrade
Jefferies
Hold → Buy
$1.30 → $3
May-06-22 Downgrade
JP Morgan
Neutral → Underweight
May-05-22 Downgrade
SVB Leerink
Outperform → Mkt Perform
$10 → $3
May-05-22 Downgrade
H.C. Wainwright
Buy → Neutral
$10 → $3
May-04-22 Downgrade
Northland Capital
Outperform → Market Perform
May-12-21 Downgrade
Goldman
Neutral → Sell
$6 → $5
Sep-29-20 Resumed
JP Morgan
Neutral
Aug-26-20 Initiated
Piper Sandler
Overweight
$21
May-05-20 Initiated
Northland Capital
Outperform
$15
Mar-31-20 Upgrade
Oppenheimer
Underperform → Perform
Mar-31-20 Downgrade
Jefferies
Buy → Hold
$30 → $4
Mar-31-20 Downgrade
Goldman
Buy → Neutral
Mar-13-20 Upgrade
Goldman
Neutral → Buy
$28
Mar-02-20 Initiated
Cowen
Outperform
$23
Feb-18-20 Upgrade
Citigroup
Neutral → Buy
$27 → $24
Jan-06-20 Initiated
JP Morgan
Neutral
$22
Dec-16-19 Downgrade
Stifel
Buy → Hold
Nov-20-19 Initiated
Oppenheimer
Underperform
$7
Show Previous Ratings
Mar-25-24 08:00AM
Mar-01-24 09:30AM
08:39AM
Feb-29-24 03:30PM
07:37AM
(Associated Press Finance)
07:34AM
Loading…
07:34AM
07:00AM
Feb-15-24 08:00AM
Jan-22-24 07:30AM
Jan-12-24 09:40AM
Jan-11-24 09:34AM
Jan-10-24 07:02PM
07:00AM
Dec-26-23 07:13PM
Dec-11-23 08:00AM
12:00PM
Loading…
Dec-05-23 12:00PM
Nov-12-23 09:00AM
Nov-02-23 10:58AM
Nov-01-23 12:30PM
12:03PM
09:30AM
09:25AM
07:30AM
(Associated Press Finance)
07:00AM
Oct-31-23 12:00PM
Oct-26-23 08:00AM
Oct-23-23 10:08AM
Oct-19-23 08:00AM
Sep-12-23 08:00AM
Aug-24-23 09:29AM
11:22AM
Loading…
Aug-19-23 11:22AM
Aug-09-23 04:05PM
Aug-08-23 07:00AM
Aug-07-23 07:00AM
Aug-03-23 11:22AM
Aug-02-23 07:33AM
07:11AM
Jul-31-23 08:00AM
Jul-28-23 02:56PM
Jul-26-23 08:00AM
Jul-25-23 04:05PM
Jul-20-23 08:00AM
Jul-19-23 12:58PM
11:19AM
Jul-18-23 04:16PM
04:15PM
Jul-05-23 11:43AM
Jun-21-23 09:00AM
Jun-08-23 11:07AM
Jun-01-23 04:30PM
06:00AM
May-23-23 09:50AM
May-12-23 11:00AM
May-03-23 02:00PM
01:47PM
07:41AM
07:00AM
May-02-23 01:32PM
Apr-19-23 08:00AM
Apr-17-23 07:00AM
Apr-13-23 10:18AM
Apr-12-23 09:18AM
Apr-04-23 03:53PM
08:00AM
Mar-16-23 08:00AM
Mar-06-23 04:05PM
09:37AM
08:00AM
Mar-05-23 10:21AM
Mar-03-23 11:09AM
Mar-02-23 01:23PM
11:44AM
05:55AM
Mar-01-23 11:02AM
11:00AM
07:00AM
Feb-28-23 11:11AM
10:39AM
10:38AM
08:00AM
Feb-27-23 04:29PM
08:00AM
07:15AM
Feb-24-23 11:52AM
Feb-22-23 04:50PM
08:00AM
Feb-21-23 08:30AM
08:00AM
Feb-20-23 01:00PM
Feb-17-23 09:03AM
07:30AM
Feb-16-23 04:05PM
12:34PM
09:44AM
Feb-15-23 04:29PM
Feb-14-23 05:09PM
09:55AM
Feb-13-23 07:47PM
09:40AM
08:00AM
Amarin Corp. Plc is a pharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. It focuses on the development and commercialization of Vascepa capsules. The company was founded by Geoffrey William Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Holt Patrick President and CEO Jan 22 '24 Buy 1.09 14,426 15,724 314,426 Jan 24 04:31 PM Ketchum Steven B Chief Scientific Officer Dec 12 '23 Sale 0.79 34,131 26,963 566,100 Dec 14 06:35 PM Holt Patrick President and CEO Aug 16 '23 Buy 1.04 300,000 312,315 300,000 Aug 16 07:51 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite